Gecina (GECFF)
(Delayed Data from OTC)
$106.21 USD
0.00 (0.00%)
Updated May 15, 2024 11:35 AM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Income Statements
Fiscal Year end for Gecina falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 660 | 600 | 650 | 677 | 754 |
Cost Of Goods | 0 | 0 | 0 | 0 | 61 |
Gross Profit | 660 | 600 | 650 | 677 | 693 |
Selling & Adminstrative & Depr. & Amort Expenses | 2,407 | 382 | -474 | 385 | -1,167 |
Income After Depreciation & Amortization | -1,747 | 218 | 1,124 | 292 | 1,860 |
Non-Operating Income | -94 | 54 | -19 | -23 | -42 |
Interest Expense | 97 | 92 | 97 | 104 | 114 |
Pretax Income | -1,939 | 180 | 1,009 | 165 | 1,704 |
Income Taxes | 2 | 4 | 2 | -11 | 5 |
Minority Interest | -6 | -2 | 2 | -1 | 2 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -1,941 | 176 | 1,006 | 176 | 1,699 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -1,934 | 179 | 1,005 | 177 | 1,697 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -1,715 | 223 | 1,138 | 389 | 1,878 |
Depreciation & Amortization (Cash Flow) | 32 | 5 | 14 | 97 | 19 |
Income After Depreciation & Amortization | -1,747 | 218 | 1,124 | 292 | 1,860 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 74.07 | 73.94 | 73.83 | 73.70 | 73.85 |
Diluted EPS Before Non-Recurring Items | 6.50 | 5.84 | 6.30 | 2.40 | 22.98 |
Diluted Net EPS (GAAP) | -26.12 | 2.41 | 12.42 | 2.40 | 22.98 |
Fiscal Year end for Gecina falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | NA | NA |
Cost Of Goods | NA | NA | NA | NA | NA |
Gross Profit | NA | NA | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | NA | NA | NA | NA | NA |
Interest Expense | NA | NA | NA | NA | NA |
Pretax Income | NA | NA | NA | NA | NA |
Income Taxes | NA | NA | NA | NA | NA |
Minority Interest | NA | NA | NA | NA | NA |
Investment Gains/Losses | NA | NA | NA | NA | NA |
Other Income/Charges | NA | NA | NA | NA | NA |
Income From Cont. Operations | NA | NA | NA | NA | NA |
Extras & Discontinued Operations | NA | NA | NA | NA | NA |
Net Income (GAAP) | NA | NA | NA | NA | NA |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | NA | NA | NA | NA |